Biogen’s (BIIB) “Hold” Rating Reiterated at Needham & Company LLC
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reissued by Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. Other equities analysts have also recently issued reports about the company. BMO Capital Markets lowered their target price on Biogen from $156.00 to $139.00 and set a “market […]
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reissued by Needham & Company LLC in a research note issued to investors on Thursday,Benzinga reports. Other equities analysts have also recently issued reports about the company. BMO Capital Markets lowered their target price on Biogen from $156.00 to $139.00 and set a “market […]
